Other Offerings. Except as disclosed in the General Disclosure Package, the Company has not sold, issued or distributed any Securities during the six-month period preceding the date hereof, including any sales pursuant to Rule 144A under, or Regulation D or S of, the Act, other than Securities issued pursuant to (i) the Company’s employee benefit plans, qualified stock option plans or other employee compensation plans, (ii) outstanding options, rights or warrants, or (iii) the conversion of outstanding preferred stock into Securities as described in the General Disclosure Package.
Appears in 3 contracts
Samples: Underwriting Agreement (Arcadia Biosciences, Inc.), Underwriting Agreement (Ooma Inc), Underwriting Agreement (Receptos, Inc.)
Other Offerings. Except as disclosed in the General Disclosure Package, the Company has not sold, issued or distributed any Securities during the six-month period preceding the date hereof, including any sales pursuant to Rule 144A under, or Regulation D or S of, the Act, other than Securities common shares issued pursuant to (i) the Company’s employee benefit benefits plans, qualified stock option plans or other employee compensation plans, (ii) plans or pursuant to the exercise or conversion of outstanding options, rights rights, warrants or warrants, or (iii) the conversion of outstanding preferred stock into Securities as described in the General Disclosure Packageconvertible debt.
Appears in 2 contracts
Samples: Underwriting Agreement (Textura Corp), Underwriting Agreement (Textura Corp)
Other Offerings. Except as disclosed in the General Disclosure Package, the Company has not sold, issued or distributed any Securities or any other equity security during the six-month period preceding the date hereof, including any sales pursuant to Rule 144A under, or Regulation D or S of, the Act, other than Securities or any other equity security issued pursuant to (i) the Company’s employee benefit plans, qualified stock option plans or other employee compensation plans, (ii) plans or pursuant to outstanding options, rights or warrants, or (iii) the conversion of outstanding preferred stock into Securities as described in the General Disclosure Package.
Appears in 2 contracts
Samples: Underwriting Agreement (NeuroSigma, Inc.), Underwriting Agreement (NeuroSigma, Inc.)
Other Offerings. Except as disclosed in the General Disclosure Package, the Company has not sold, issued or distributed any Securities ordinary shares during the six6-month period preceding the date hereof, including any sales pursuant to Rule 144A under144A, or Regulation under Regulations D or S of, the Act, other than Securities ordinary shares issued pursuant to (i) the Company’s employee benefit incentive plans, qualified stock option plans or other employee compensation plans, (ii) or pursuant to outstanding options, rights or warrants, or (iii) the conversion of outstanding preferred stock into Securities each as described in the General Disclosure Package, the Registration Statement and the Final Prospectus.
Appears in 1 contract
Other Offerings. Except as disclosed in the General Disclosure Package, the Company has not sold, issued or distributed any Securities during the six-month period preceding the date hereof, including any sales pursuant to Rule 144A under, or Regulation D or S of, the Act, other than Securities issued pursuant to (iA) the Company’s employee benefit plans, qualified stock option plans or other employee compensation plans, (iiB) pursuant to outstanding options, rights or warrants, or (iiiC) the conversion of the outstanding preferred stock into Securities as described in the General Disclosure Package.
Appears in 1 contract
Samples: Underwriting Agreement (Alder Biopharmaceuticals Inc)
Other Offerings. Except as disclosed in the General Disclosure Package, the Company has not sold, issued or distributed any Securities during the six-month period preceding the date hereof, including any sales pursuant to Rule 144A under, or Regulation D or S of, the Act, other than Securities issued pursuant to (iA) the Company’s employee benefit plans, qualified stock option plans or other employee compensation plans, (ii) outstanding options, rights or warrants, or (iiiB) the conversion of pursuant to outstanding preferred stock into Securities as described in the General Disclosure Packageoptions or rights.
Appears in 1 contract
Samples: Underwriting Agreement (Alder Biopharmaceuticals Inc)
Other Offerings. Except as disclosed in the General Disclosure Package, the Company has not sold, issued or distributed any Securities securities during the six-month period preceding the date hereof, including any sales pursuant to Rule 144A under, or Regulation D or S of, the Act, other than Securities securities issued pursuant to (i) the Company’s employee benefit plans, qualified stock option plans or other employee compensation plans, (ii) outstanding options, rights or warrants, or (iii) the conversion of outstanding preferred stock into Securities securities as described in the General Disclosure Package.
Appears in 1 contract
Samples: Purchase Agreement (Ooma Inc)